What is Tirzepatide in research?
It is a synthetic dual GIPR and GLP-1R agonist used to study incretin receptor signalling and metabolic biology.
Research materialResearch use only
Documentation
Live catalogue
Technical Specifications
A dual-incretin receptor agonist peptide. Live Commerce records remain the authority for the available formulation, strength, inventory, and price.
Back to catalogue
Research material
Tirzepatide
Tirzepatide is a synthetic peptide investigated as a dual agonist at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These class B G-protein-coupled receptors participate in nutrient-responsive endocrine signalling. In laboratory work, Tirzepatide is used as a defined tool for examining how simultaneous incretin-receptor engagement differs from signalling through either receptor alone. Its peptide design, receptor selectivity, and pharmacology make it relevant to studies of energy balance, pancreatic islet biology, hepatic metabolism, and systemic metabolic communication. This material is supplied for qualified laboratory research only, not for human or veterinary use.
Research highlights
- Incretin biology; metabolic and endocrine signalling; receptor pharmacology; pancreatic islet models; nutrient-sensing pathways; peptide-receptor structure–function research.
- The scientific literature includes receptor-binding, cellular, animal, and clinical research. This page describes research context rather than clinical guidance or expected outcomes.
Select size / quantity
Select Volume
Live CAD price
$79.99
Selected size
Tirzepatide 10MGQuantity
1
For research purposes only. Not for human or veterinary use.
Free shipping on orders over $250 CAD
Multi-unit savings: 3 units — 10% off · 5 units — 15% off · 10 units — 20% off. Promotional savings are subject to confirmation at checkout.
Technical Specifications
A dual-incretin receptor agonist peptide. Live Commerce records remain the authority for the available formulation, strength, inventory, and price.
Research use only
Materials are intended strictly for laboratory and analytical research.
Contact research supportMechanism & Research Pathways
Established pharmacology identifies GIPR and GLP-1R as the principal targets. Both receptors commonly couple to Gs proteins and cAMP-linked intracellular signalling, although downstream responses vary by cell type, ligand kinetics, and experimental model. Studies use dual agonism to investigate receptor crosstalk, insulinotropic signalling, glucagon regulation, gastric and central neuroendocrine pathways, and biased agonism. Observations about tissue-level or organism-level outcomes should be interpreted in the context of the model used; cellular and preclinical findings do not by themselves establish a clinical outcome.
Research Context
The scientific literature includes receptor-binding, cellular, animal, and clinical research. This page describes research context rather than clinical guidance or expected outcomes.
Frequently Asked Research Questions
Which receptors does Tirzepatide interact with?
Its established primary pharmacology is activity at GIP and GLP-1 receptors.
Why study dual agonism?
Dual agonism can help researchers compare coordinated receptor signalling with single-receptor experimental conditions.